HSHHSH Health Technology Supplier Hub
Home › Suppliers › Sectra › Risk

Sectra: risk summary

Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.

Financial

Latest full-year results from official filings.

FY2025/26 revenue SEK 3.54bn (+9.3%); operating margin 20.1%; net income SEK 563.8m.

Prior year included a SEK 110m one-off patent settlement.

Researched 8 Nov 2026

Adverse media

Credible news about incidents, disputes, legal action or restructuring in the last 24 months.

No adverse media involving Sectra found in HSH's search of the last 24 months.

Researched 10 Nov 2026

Cyber & information governance

Data breaches, cyber incidents, regulator action and assurance status.

Oct 2025: Sectra notified customers of a critical security vulnerability in several Sectra Core versions that could affect confidentiality, integrity and availability of patient data; Health Canada listed it as a Type II recall and France's ANSM published a safety notice. NHS DSPT status not yet checked.

Researched 10 Nov 2026

Regulatory & clinical safety

Recalls, safety notices, regulator action and clinical safety concerns.

Oct 2025: the Sectra Core security vulnerability was handled as a medical device recall/field safety action (Health Canada Type II). No other recalls or regulator actions involving Sectra found in HSH's search of the last 24 months.

Researched 10 Nov 2026